$NLNK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LUMOS PHARMA, INC.. Get notifications about new insider transactions in LUMOS PHARMA, INC. for free.
Page: < prev 1 2 3 4 5 6 ... 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 2,392 | 4,234 | 2,392 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 10.78 | 4,783 | 51,561 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 8,887 | 15,730 | 8,887 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 10.78 | 17,773 | 191,593 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 1,588 | 2,811 | 1,588 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 44.60 | 6,349 | 283,165 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 5,220 | 9,239 | 5,220 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 21.23 | 15,659 | 332,441 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 4,000 | 7,080 | 4,000 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 14.71 | 12,000 | 176,520 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 3,571 | 6,321 | 3,571 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 13.30 | 10,713 | 142,483 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 3,968 | 7,023 | 3,968 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 13.30 | 11,904 | 158,323 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 14,293 | 25,299 | 14,293 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 24,250 | 42,923 | 24,250 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 11,458 | 20,281 | 11,458 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 3.17 | 100,000 | 317,000 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,291 | 4,055 | 2,291 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,291 | 4,055 | 2,291 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,293 | 4,059 | 2,293 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 3,438 | 6,085 | 3,438 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 3,438 | 6,085 | 3,438 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 4,297 | 7,606 | 4,297 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 4,870 | 8,620 | 4,870 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 4,583 | 8,112 | 4,583 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 7.85 | 55,000 | 431,750 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 4,821 | 8,533 | 4,821 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,211 | 3,913 | 2,211 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 11,719 | 20,743 | 11,719 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 10.55 | 37,500 | 395,625 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 330 | 584 | 330 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 278 | 492 | 278 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 9,392 | 16,624 | 9,392 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 10.78 | 20,000 | 215,600 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 281 | 497 | 281 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 328 | 581 | 328 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 1,639 | 2,901 | 1,639 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 34.73 | 8,989 | 312,188 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 589 | 1,043 | 589 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 3,487 | 6,172 | 3,487 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 43.65 | 16,300 | 711,495 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,309 | 4,087 | 2,309 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 6,692 | 11,845 | 6,692 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 21.38 | 27,000 | 577,260 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 3,129 | 5,538 | 3,129 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 3,539 | 6,264 | 3,539 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 11.79 | 20,000 | 235,800 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,028 | 3,590 | 2,028 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 5,472 | 9,685 | 5,472 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 6.87 | 15,000 | 103,050 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,867 | 5,075 | 2,867 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 9,038 | 15,997 | 9,038 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 7.00 | 23,809 | 166,663 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 8,333 | 14,749 | 8,333 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 7.00 | 16,666 | 116,662 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 1,190 | 2,106 | 1,190 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 3.07 | 2,380 | 7,307 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 100,000 | 177,000 | 100,000 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 5,269 | 9,326 | 5,269 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 5,269 | 9,326 | 5,269 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 5,275 | 9,337 | 5,275 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 6,158 | 10,900 | 6,158 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 7,907 | 13,995 | 7,907 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 7,907 | 13,995 | 7,907 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 14,926 | 26,419 | 14,926 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 10,542 | 18,659 | 10,542 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 7.85 | 126,500 | 993,025 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 3,477 | 6,154 | 3,477 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 19,531 | 34,570 | 19,531 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 19,531 | 34,570 | 19,531 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 19,532 | 34,572 | 19,532 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 19,532 | 34,572 | 19,532 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 25,820 | 45,701 | 25,820 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 48,828 | 86,426 | 48,828 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 10.55 | 312,500 | 3,296,875 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 439 | 777 | 439 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 190 | 336 | 190 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 2,195 | 3,885 | 2,195 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 18,246 | 32,295 | 18,246 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 34.73 | 84,275 | 2,926,871 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 813 | 1,439 | 813 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 19,438 | 34,405 | 19,438 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 43.65 | 81,000 | 3,535,650 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 1,710 | 3,027 | 1,710 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 22,041 | 39,013 | 22,041 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 21.38 | 71,250 | 1,523,325 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 3,129 | 5,538 | 3,129 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 26,872 | 47,563 | 26,872 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 11.79 | 90,000 | 1,061,100 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 8,080 | 14,302 | 8,080 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 31,921 | 56,500 | 31,921 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 6.87 | 80,000 | 549,600 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 7,143 | 12,643 | 7,143 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 14,286 | 25,286 | 14,286 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 7.00 | 42,857 | 299,999 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 95,238 | 168,571 | 95,238 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 3.07 | 190,476 | 584,761 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 22,580 | 39,967 | 22,580 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 167,896 | 297,176 | 167,896 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 2.97 | 380,952 | 1,131,427 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 4,437 | 7,853 | 4,437 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 17.42 | 13,309 | 231,843 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 2,391 | 4,232 | 2,391 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 10.78 | 4,782 | 51,550 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 8,887 | 15,730 | 8,887 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 10.78 | 17,774 | 191,604 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 1,588 | 2,811 | 1,588 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 44.60 | 6,349 | 283,165 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 5,220 | 9,239 | 5,220 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 21.23 | 15,659 | 332,441 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 4,000 | 7,080 | 4,000 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 14.71 | 12,000 | 176,520 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 5,952 | 10,535 | 5,952 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 13.30 | 17,855 | 237,472 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 23,810 | 42,144 | 23,810 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 7.00 | 47,619 | 333,333 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 1,786 | 3,161 | 1,786 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 7.00 | 3,571 | 24,997 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 8,929 | 15,804 | 8,929 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 10.02 | 17,857 | 178,927 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 13,095 | 23,178 | 13,095 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 3.07 | 26,190 | 80,403 | 0 | |
| Jun 24 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Payment of Exercise | F | 1.57 | 359 | 564 | 14,097 | 14.5 K to 14.1 K (-2.48 %) |
| Jun 24 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Payment of Exercise | F | 1.57 | 359 | 564 | 14,097 | 14.5 K to 14.1 K (-2.48 %) |
| May 14 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
| May 14 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
| May 14 2019 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
| May 14 2019 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
| May 14 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
| Mar 05 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.80 | 185,000 | 333,000 | 185,000 | |
| Mar 05 2019 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | A | 1.80 | 500,000 | 900,000 | 500,000 | |
| Mar 05 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.80 | 185,000 | 333,000 | 185,000 | |
| Mar 05 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.80 | 185,000 | 333,000 | 185,000 | |
| Mar 05 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.80 | 50,000 | 90,000 | 50,000 | |
| Jan 04 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Payment of Exercise | F | 1.55 | 398 | 617 | 20,425 | 20.8 K to 20.4 K (-1.91 %) |
| Jan 04 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Payment of Exercise | F | 1.66 | 646 | 1,072 | 20,823 | 21.5 K to 20.8 K (-3.01 %) |
| Jan 04 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Payment of Exercise | F | 1.55 | 2,626 | 4,070 | 48,553 | 51.2 K to 48.6 K (-5.13 %) |
| Jan 04 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Payment of Exercise | F | 1.66 | 2,229 | 3,700 | 51,179 | 53.4 K to 51.2 K (-4.17 %) |
| Jan 04 2019 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Payment of Exercise | F | 1.55 | 5,906 | 9,154 | 250,801 | 256.7 K to 250.8 K (-2.30 %) |
| Jan 04 2019 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Payment of Exercise | F | 1.66 | 5,699 | 9,460 | 256,707 | 262.4 K to 256.7 K (-2.17 %) |
| Jan 04 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Payment of Exercise | F | 1.55 | 376 | 583 | 13,516 | 13.9 K to 13.5 K (-2.71 %) |
| Dec 14 2018 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | M | 0.80 | 2,564 | 2,051 | 0 | |
| Dec 14 2018 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Buy | M | 0.80 | 2,564 | 2,051 | 262,406 | 259.8 K to 262.4 K (+0.99 %) |
| Dec 14 2018 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | M | 0.80 | 2,564 | 2,051 | 0 | |
| Dec 14 2018 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Buy | M | 0.80 | 2,564 | 2,051 | 21,469 | 18.9 K to 21.5 K (+13.56 %) |
| Oct 02 2018 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | Chief Administrativ ... | Payment of Exercise | F | 2.28 | 2,484 | 5,664 | 55,052 | 57.5 K to 55.1 K (-4.32 %) |
| Aug 03 2018 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 3.17 | 100,000 | 317,000 | 100,000 |